FERNANDO ATAULFO
GONZÁLEZ FERNÁNDEZ
Profesor asociado de Ciencias de la Salud
GlaxoSmithKline (United Kingdom)
Londres, Reino UnidoGlaxoSmithKline (United Kingdom)-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2019
-
Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor–experienced adult patients with PNH: The 302 study
Blood, Vol. 133, Núm. 6, pp. 540-549